Sarah London bought $250K of Centene (CNC)
Executed Nov 8 2024, disclosed Nov 8 2024, the same day.
Over the 21 trading sessions from the disclosed entry session (Nov 8 2024), the stock returned -6.9% (delay-adjusted); from the execution session (Nov 8 2024), -6.9%. Derived: entry at the session's open, exit at the close 20 sessions later.
Sarah London (Chief Executive Officer) filed 2 Form 4 reports in the past 24 months (2 purchases, 0 sales), most often in Centene Corporation (CNC). Across 2 priced purchase filings, the average 21-session return was +3.5% from execution and +7.7% from disclosure (delay-adjusted; derived). The largest single filing was $490K of CNC (19,230 sh × $25.50, as filed), executed Aug 8 2025.
Healthcare · Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organi…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→19,230 sh × $25.50
Exec Aug 8 2025
Filed Aug 11 2025 · 5:28 PM ET